Welcome to LookChem.com Sign In|Join Free

CAS

  • or

123953-16-2

Post Buying Request

123953-16-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

123953-16-2 Usage

Synthesis Reference(s)

Journal of Heterocyclic Chemistry, 26, p. 1345, 1989 DOI: 10.1002/jhet.5570260523

Check Digit Verification of cas no

The CAS Registry Mumber 123953-16-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,9,5 and 3 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 123953-16:
(8*1)+(7*2)+(6*3)+(5*9)+(4*5)+(3*3)+(2*1)+(1*6)=122
122 % 10 = 2
So 123953-16-2 is a valid CAS Registry Number.

123953-16-2Relevant articles and documents

New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors

Segretti, Natanael D.,Serafim, Ricardo A.M.,Segretti, Mariana C.F.,Miyata, Marcelo,Coelho, Fernando R.,Augusto, Ohara,Ferreira, Elizabeth I.

, p. 3988 - 3993 (2016)

The development of resistance to antibiotics by microorganisms is a major problem for the treatment of bacterial infections worldwide, and therefore, it is imperative to study new scaffolds that are potentially useful in the development of new antibiotics

Synthesis and characterization of a new family of energetic salts based on guanidinium cation containing furoxanyl functionality

Wu, Bo,Wang, Zhixin,Yang, Hongwei,Lin, Qiuhan,Ju, Xuehai,Lu, Chunxu,Cheng, Guangbin

, p. 58243 - 58251 (2014)

A new family of energetic salts based on a new guanidinium cation containing furoxanyl functionality, 1-(3′-methylfuroxanyl)methyleneamino guanidinium cation, were synthesized and well characterized by IR and multinuclear NMR spectroscopy, elemental analysis as well as differential scanning calorimetry. The structures of salts 1, 4, 5 and 6 were confirmed by single-crystal X-ray diffraction. Most of the salts decompose at temperatures over 180 °C. Furthermore, except for salts 7 and 9, the remaining energetic salts exhibit low impact sensitivities (15-40 J), friction sensitivities (120-360 N), and are insensitive to electrostatics. The detonation pressure values calculated for these salts range from 19.3 to 27.5 GPa, and the detonation velocities range from 7515 to 8402 m s-1. These results make some energetic salts potential candidates for energetic materials with good thermal stabilities and low sensitivities. This journal is

Synthesis and preliminary evaluation of N-oxide derivatives for the prevention of atherothrombotic events

Rosseto, Leandro Augusto,Pires, Maria Elisa Lopes,Melchior, Aylime Castanho Bolognesi,Bosquesi, Priscila Longhin,Pavan, Aline Renata,Marcondes, Sisi,Chung, Man Chin,Dos Santos, Jean Leandro

, p. 18185 - 18200 (2015)

Thrombosis is the main outcome of many cardiovascular diseases. Current treatments to prevent thrombotic events involve the long-term use of antiplatelet drugs. However, this therapy has several limitations, thereby justifying the development of new drugs

In Vitro Metabolic Stability and in Vivo Biodistribution of 3-Methyl-4-furoxancarbaldehyde Using PET Imaging in Rats

Pippin, Adam B.,Mohd Arshad, Zaira Hidayah,Voll, Ronald J.,Nye, Jonathon A.,Ghassabian, Sussan,Williams, Craig M.,Mancini, Alessandra,Liotta, Dennis C.,Smith, Maree T.,Goodman, Mark M.

, p. 563 - 567 (2016)

Painful diabetic neuropathy (PDN) is a type of peripheral neuropathic pain that is currently difficult to treat using clinically available analgesics. Recent work suggests a progressive depletion of nitric oxide (NO) in nerve cells may be responsible for the pathobiology of PDN. The nitric oxide donor, 3-methyl-4-furoxancarbaldehyde (PRG150), has been shown to produce dose-dependent analgesia in a rat model of PDN. To gain insight into the mechanism of analgesia, methods to radiolabel PRG150 were developed to assess the in vivo biodistribution in rats. The furoxan ring was labeled with 13N to follow any nitric oxide release and the 3-methyl substituent was labeled with 11C to track the metabolite using PET imaging. The in vitro metabolic stability of PRG150 was assessed in rat liver microsomes and compared to in vivo metabolism of the synthesized radiotracers. PET images revealed a higher uptake of 13N over 11C radioactivity in the spinal cord. The differences in radioactive uptake could indicate that a NO release in the spinal cord and other components of the somatosensory nervous system may be responsible for the analgesic effects of PRG150 seen in the rat model of PDN.

Schiff bases containing a furoxan moiety as potential nitric oxide donors in plant tissues

Georgescu, Emilian,Oancea, Anca,Georgescu, Florentina,Nicolescu, Alina,Oprita, Elena Iulia,Vladulescu, Lucian,Vladulescu, Marius-Constantin,Oancea, Florin,Shova, Sergiu,Deleanu, Calin

, (2018)

Stable Schiff bases containing a furoxan moiety are synthesized as single regioisomers by the reaction of 3-methyl-2-oxy-furazan-4-carbaldehydewith various amino compounds at room temperature. The structures of synthesized compounds were fully characterized by multinuclear NMR spectroscopy and X-ray crystallography. The effect of synthesized Schiff bases containing a furoxan moiety on biological generation of reactive oxygen species and nitric oxide in plant tissues was investigated for the first time by fluorescence microscopy and the released NO identified as nitrite with Griess reagent. There is a good correlation between the biological generation of NO determined by fluorescence microscopy and with Griess reagent. Some of the synthesized compounds exhibited both nitric oxide and reactive oxygen species generation abilities and represent potential NO donors in plant tissues.

Synthesis and biological evaluation of some new furoxan derivatives as anti-inflammatory agents

Amir, Mohd,Verma, Jeevan S.,Tariq, Sana,Somakala,Ehtaishamul Haq

, p. 955 - 959 (2019/05/21)

A new series of furoxan derivatives (3a-k) have been synthesized and characterized by their IR, 1H NMR and mass spectral data. All the compounds have been screened for their anti-inflammatory activity. The compounds 3a, 3b, 3f, 3g, and 3i which show significant anti-inflammatory activity have been further studied for their ulcerogenic activities and nitric oxide releasing properties. Furoxan derivative 3-memyl-4-[{2-(2-phenylacetyl)hydrazono}memyl]-furoxan 3f showed greater anti-inflammatory activity comparable to standard drug ibuprofen. The compound also showed reduced, ulcerogenicity and high nitric oxide releasing properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 123953-16-2